Societal CDMO, Inc. announced that it has signed work order extensions with multiple existing customers that span a variety of the company's CDMO service areas of expertise. The expansion of the scope of work of existing customers continues to be a strategic area of growth for the company, complementing its parallel efforts dedicated to the securing of new customers. The recently signed work expansions agreements include: Manufacturing of additional engineering batch of an antibiotic capsule formulation for the treatment of Staphylococcus aureus infections.

Analytical method transfer, evaluation, and validation for an investigational treatment for attention-deficit/hyperactivity disorder (ADHD). Preparation and execution of a stability protocol, as well as a compatibility study, for an investigational cancer therapy. Clinical trial services focused on product encapsulation, packaging, and labeling for an investigational treatment for depression.